• Title/Summary/Keyword: nasopharyngeal carcinoma

검색결과 182건 처리시간 0.027초

두경부 편평세포암종에서 상피성장인자수용체의 발현과 세포주기에 관한 연구 (EXPRESSION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND CELL CYCLE ANALYSIS IN THE HEAD AND NECK SQUAMOUS CELL CARCINOMAS)

  • 김경원;김명진
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제26권2호
    • /
    • pp.154-163
    • /
    • 2000
  • Growth factors and the receptors play an important role in the regulation of the growth and development of mammalian cells. In particular, epidermal growth factor is a polypeptide with potent mitogenic activity that stimulates proliferation of various normal and neoplastic cells through the interaction with its specific receptor(EGFR). EGFR has been described as a parameter of poor prognosis in many human neoplasms such as breast, bladder, and vulvar cancers. The objectives of this study are the evaluation of the expression of EGFR and cell cycle analysis in the head and neck squamous cell carcinomas(SCC), and the evaluation of the correlation between clinico-patholgic features and expression of EGFR and S-phase fraction. 37 head and neck squamous cell carcinoma specimens were evaluated for expression of EGFR by Western blot analysis and S-phase fraction by cell cycle analysis using the flow cytometry. The obtained results were as follows : 1. The expressions of EGFR were observed in 20 specimens(54%) among 37 head and neck SCC specimens. In case of oral SCC, 15 specimens(56%) out of 27 specimens were observed, and in case of nasopharyngeal SCC 5 specimens(50%) out of 10 specimens. 2. There was no correlation between clinical features(location, stage) of head and neck SCC and expression of EGFR (p>0.05). 3. There was a significant correlation between histo-pathological differentiation of head and neck SCC and expression of EGFR (p<0.02). 4. There was a significant correlation between expression of EGFR and S-phase fraction of cell cycle in the head and neck SCC (p<0.05). The above results suggest that expression of EGFR and S-phase fraction of cell cycle are adjunctive prognostic marker in the head and neck squamous cell carcinomas.

  • PDF

MTA1 Overexpression Induces Cisplatin Resistance Innasopharyngeal Carcinoma by Promoting Cancer Stem Cells Properties

  • Feng, Xiaohua;Zhang, Qianbing;Xia, Songxin;Xia, Bing;Zhang, Yue;Deng, Xubin;Su, Wenmei;Huang, Jianqing
    • Molecules and Cells
    • /
    • 제37권9호
    • /
    • pp.699-704
    • /
    • 2014
  • Themetastasis-associated gene 1 (MTA1) oncogene hasbeen suggested to be involved in the regulation of cancer progression. However, there is still no direct evidence that MTA1 regulates cisplatin (CDDP) resistance, as well as cancer stem cell properties. In this study, we found that MTA1 was enriched in CNE1/CDDP cells. Knock down of MTA1 in CNE1/CDDP cells reversed CSCs properties and CDDP resistance. However, ectopic expression of MTA1 in CNE1 cells induced CSCs phenotypes and CDDP insensitivity. Interestingly, ectopic overexpression of MTA1-induced CSCs properties and CDDP resistance were reversed in CNE1 cells after inhibition of PI3K/Akt by LY294002. In addition, MTA1 expression and Akt activity in CNE1/CDDP cells was much higher than that in CNE1 cells. These results suggested that MTA1 may play a critical role in promoting CDDP resistance in NPC cells by regulatingcancer stem cell properties via thePI3K/Akt signaling pathway. Our findings suggested that MTA1 may be a potential target for overcoming CDDP resistance in NPC therapy.

비인강암의 방사선치료 : RTOG에서 제시한 PPC와 생존율에 대한 고찰 (A Study of Relationship Between PPC (Probability of Primary Clearance: a multivariate modelling system predicting tumor clearance proposed by RTOG) and Survival in the Patients with Carcinoma of the Nasopharynx following Radiation Therapy)

  • 조관호;박경란;오원용;전미선;서창옥;김귀언;노준규
    • Radiation Oncology Journal
    • /
    • 제4권1호
    • /
    • pp.45-50
    • /
    • 1986
  • 1984년 RTOG에서 두경부 편평세포암의 방사선치료시, 원발병소의 완전관해 가능성을 예측할 수 있는 Multivariate Modelling System을 제시하였다. 저자들은 1971년 1월부터 1983년 12월까지 조직병리학적으로 확진된 비인강암으로 연계대학교 의과대학 연세암센타, 치료방사선과에 내원하여 근치적 방사선 치료를 받은 81예를 대상으로, 그들이 제시한 system에 의해 계산된 PPC(Probability of Primary Clearance : 원발병소 완전관해 가능성)와 생존율과의 관계를 후향적으로 분석 고찰하였다. 전례를 대상으로 한 5년 생존율은 $36\%$, 중앙생존기간은 39개월이었다. 편의상, PPC에 따라 3군으로 구분하였고, 각군에 따른 생존율은 Group 1 (PPC가 $81\%$이상인 27예)은 $66\%$(중앙생존기간: 72개월 이상), Group 2(PPC가 $71\~80\%$의 20예)는 $27\%$(31개월) 및 Group 3(PPC가 $70\%$ 이하의 29예)의 $4\%$(12개월)순이었다. 그러고 각 Group간의 PPC와 생존율은 통계학적으로 유의한 차이를 보였다.

  • PDF

Epstein-Barr 바이러스 인사이투 보결합 시행시 양성대조표지로서의 버키트 림프종 세포주 (CCL85 EB-3)의 응용 (Application of Epstein-Barr Virus Cell Lines (CCL85 EB-3) in Performing the EBER mRNA In Situ Hybridization as a Positive Control)

  • 김성숙;한운섭;서주영;허주령
    • 대한세포병리학회지
    • /
    • 제7권1호
    • /
    • pp.38-43
    • /
    • 1996
  • Epstein-Barr virus(EBV) is associated with a wide spectrum of benign and malignant disorders including leukoplakia, Hodgkln's lymphoma, central nervous system lymphoma, peripheral T cell lymphoma and nasopharyngeal undifferentiated carcinoma. There are several distinctive aspects of biology of the virus that are important in investigation of virus in clinical specimens. The abundant expression of the EBER mRNA transcripts makes possible the sensitive detection of latent expression in EBV-associated tumors. Although there has been a dramatic increased interest in the direct characterization of EBV in clinical specimens, there have been few studios about the effective and reliable positive controls in performing in situ hybridization technique for EBV, especially on paraffin-em bedded tissue. We applied Burkitts lymphoma ceil line as positive control in EBV in situ hydridization using Oncor Kit. The cell block of Burkitt lymphoma cell line(CCL85 EB-3) showed strong and specific positivity for EBER in situ in nuclei of EBV infected cells.

  • PDF

Anti-tumor Promoting Activity of Some Malaysian Traditional Vegetable (Ulam) Extracts by Immunoblotting Analysis of Raji Cells

  • Ali, A.M.;Mooi, L.Y.;Yih, K. Yih;Norhanom, A.W.;Saleh, K. Mat;Lajis, N.H.;Yazid, A.M.;Ahmad, F.B.H.;Prasad, U.
    • Natural Product Sciences
    • /
    • 제6권3호
    • /
    • pp.147-150
    • /
    • 2000
  • The extracts of Carica papaya (flower), Barringtonia macrostachya (leaves), Coleus tuberosus (tuber), Mangifera indica (fruit skin) and Eugenia polyantha (leaves) showed strong in vitro anti-tumor promoting activity when assayed using Raji cells (Mooi et al., 1999). The antitumor promoting activity of the crude extracts was further analyzed by immunoblotting analysis of Raji cells carving Epstein-Barr virus genome. The expression of early antigens diffuse (EA-D) and early antigens restricted (EA-R) was determined by performing western blotting of treated Raji cells with human sera of nasopharyngeal carcinoma patients. All the plant extracts were shown to be able to suppress both EA-D and EA-R.

  • PDF

Pontine Necrosis Related with Radiation Therapy, Complicated with Spontaneous Hemorrhage

  • Kim, Ha Min;Hong, Bo Young;Lee, Jong In;Kim, Joon Sung;Lim, Seong Hoon
    • Brain & NeuroRehabilitation
    • /
    • 제10권1호
    • /
    • pp.1-6
    • /
    • 2017
  • The brain necrosis induced by radiation therapy (RT) is an uncommon pathology of brain. A case of spontaneous hemorrhage at necrotic brain is also rare. A 52-year-old man who had nasopharyngeal carcinoma and had been treated with RT, presented with gait disturbance, dizziness, ataxia, dysarthria, and dysphagia. Magnetic resonance imaging (MRI) demonstrated progressed radiation necrosis of pons, and spontaneous hemorrhage at the site of necrosis. The hematoma was diminished by conservative treatment. However, the patient's neurologic symptoms did not recover. Two years later, spontaneous bleeding recurred at necrotic brain. His neurologic symptoms worsened. One year later, his neurologic symptoms were more progressed. He showed severe dysphagia, profound weakness and respiratory failure. This case provides the description of relapsed spontaneous hemorrhage and medullary dysfunction caused by pontine necrosis and progressed post-radiation injury, complicated with hemorrhage, and urges caution in that the necrotic brain tissue may be vulnerable to bleeding.

동시성 및 이시성 5중 원발암의 증례 보고 (A Case Report of Synchronous and Metachronous Quintuple Primary Malignant Tumors)

  • 이정현;조혜기;장동기;강현우;김재학;임윤정;이준규
    • Journal of Digestive Cancer Research
    • /
    • 제6권1호
    • /
    • pp.36-39
    • /
    • 2018
  • 여러 가지 원인으로 인해 다발성 원발암은 증가하고 있으며, 발생 가능성을 염두에 두고 필요한 선별 검사를 시행하여야 적절한 치료가 이루어질 수 있다. 저자들은 국내에서는 보고된 적이 없고 전세계적으로도 희귀한 5중 원발암의 증례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

  • PDF

Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South Korea

  • Sung, Soo Yoon;Kang, Min Kyu;Kay, Chul Seung;Keum, Ki Chang;Kim, Sung Hwan;Kim, Yeon-Sil;Kim, Won Taek;Kim, Ji-Yoon;Kim, Jin-Hee;Moon, Sung Ho;Ahn, Yong Chan;Oh, Young Taek;Wu, Hong-Gyun;Lee, Chang-Geol;Chung, Woong-Ki;Cho, Kwan Ho;Cho, Moon-June;Choi, Jin Hwa
    • Radiation Oncology Journal
    • /
    • 제33권3호
    • /
    • pp.188-197
    • /
    • 2015
  • Purpose: To investigate the patterns of care for patients with nasopharyngeal carcinoma (NPC) in South Korea. Materials and Methods: A multi-institutional retrospective study was performed (Korean Radiation Oncology Group [KROG] 11-06) on a total of 1,445 patients from 15 institutions. Results: Of the 1,445 patients, more than half were stages III (39.9%) and IV (35.8%). In addition to patterns of care, we also investigated trends over time with the periods 1988-1993, 1994-2002, and 2003-2011. The frequencies of magnetic resonance imaging and positron emission tomography-computed tomography were markedly increased in the third period compared to previous 2 periods. Concurrent chemoradiation (CCRT) was performed on 894 patients (61.9%), neoadjuvant chemotherapy on 468 patients (32.4%), and adjuvant chemotherapy on 366 patients (25.3%). Of stage II-IV patients, CCRT performed on 78.8% in 2003-2011 compared to 15.0% in 1988-1993. For patients treated with CCRT, cisplatin was the most commonly used agent in 81.3% of patients. Over the periods of time, commonly used radiotherapy (RT) techniques were changed from 2-dimensional RT (1988-1993, 92.5%) to 3-dimensional RT (2003-2011, 35.5%) or intensity-modulated RT (IMRT; 2003-2011, 56.5%). Median RT doses given to primary tumors, high-risk lymphatics, and low-risk lymphatics were 70.0 Gy, 58.1 Gy, and 48.0 Gy, respectively. Adoption of IMRT increased the dose per fraction and escalated total radiation dose. Conclusion: Assessment of the patterns of care for NPC patients in South Korea demonstrated that management for NPC including diagnostic imaging, treatment regimen, RT techniques and dose schedule, advanced in accordance with the international guidelines.

비인강암 환자의 예후에서 $2-[18^F]$ Fluoro-2-Deoxy-D-Glucose PET 영상에서 계산되는 Standardized Uptake Value의 의의 (Prediction of Prognosis to Concurrent Chemo-Radiotherapy by Standardized Uptake Value of $2-[18^F]$ Fluovo-2-Deoxy-D-Glucose for Nasopharyngeal Carcinomas)

  • 이상욱;임기천;남순열;김재승;최은경;안승도;신성수;류진숙;김상윤;이봉재;최승호;김성배;문대혁
    • Radiation Oncology Journal
    • /
    • 제23권1호
    • /
    • pp.9-16
    • /
    • 2005
  • 목적 : 원격존기의 전이가 없는 비인강암에서 동시항암화학방사선치료를 시행 받은 환자에서 진단 당시 시행한 양전자단층촬영의 fluorodeoxyglucose (FDG) 섭취정도가 예후에 미치는 영향을 알아보고자 하였다. 대상 및 방법 : 본원에서 원격장기의 전이가 없는 비인강암으로 진단 받고 진단 당시 ($[18^F]$FDG-PET을 시행한 환자는 총 41명이었다. PET 검사는 모두 항암방사선치료 전에 시행되었다. FOG 섭취 정도를 알아보기 위해서 종양 내에서 측정된 최대 standardized uptake value (SUV)를 측정하였다. 결과 : 항암화학방사선지료 후 모든 환자는 완전반응을 보였다. 전체 41명 중에서 10명이 재발하였는데 재발하지 않은 환자의 $SUV_{max}$ 중앙값은 6.48 (range: $2.31\~26.07$)이었고 재발한 환자의 중앙 $SUV_{max}$$8.55(2.49\~14.81)$이었다. 양 군 간의 5UV의 차이는 p값이 0.0505로 통계적 차이가 관찰되지 않았다. $SUV_{max}$를 중앙값을 기준으로 나누어 보았을 때 $SUV_{max}$가 높은 환자의 3년 생존율이 통계적으로 유의하게 저조하였다($51\%\;{\nu}91\%$, p=0.0070). 결론 : 원격전이가 없는 비인강암에서 항암화학방사선치료를 시행 받은 환자에서 진단 당시 시행한 FDG 섭취 정도는 예후를 예측하는데 유용할 것으로 생각되었다. 따라서 진단 당시 시행한 FDG-PET에서 SUV가 높은 경우(8 이상)에는 좀더 적극적인 치료가 필요할 것으로 생각하였다.

비인강암에서 방사선 구강 건조증 발생 감소를 위한 3차원 입체조형치료 (Parotid Gland Sparing Radiotherapy Technique Using 3-D Conformal Radiotherapy for Nasopharyngeal CarcinomB)

  • 임지훈;김귀언;금기창;서창옥;이상욱;박희철;조재호;이상훈;장세경;노준규
    • Radiation Oncology Journal
    • /
    • 제18권1호
    • /
    • pp.1-10
    • /
    • 2000
  • 목적 : 비인강암에서 방사선치료는 근치적 목적으로 사용되고 있으나 방사선치료 후 이하선 기능 저하에 따른 구강 건조증이 생기는 것이 문제이다. 방사선치료에 의한 구강 건조증의 발생을 감소시키기 위해 방사선조사시 이하선을 보호하는 새로운 치료 기법을 개발하고자 하였다. 대상 및 방법 : 림프절 전이가 없고 종양의 침범 범위가 서로 상이한 비인강암 4례를 대상으로 2가지의 새로운 치료계획을 수립하고 기존의 2차원 통상치료계획과 비교하였다. 치료계획-A는 기존의 2차원 통상치료 방법이며, 치료계획-B는 져 Gy 이후에 축소조사를 3차원 입체 조형치료로 하는 것이며, 치료계획-C는 방사선 치료 처음부터 3차원 입체 조형치료를 이용하여 양측 이하선을 방사선 조사영역에서 제외시키면서 30.6 Gy에서 척수 차폐를 시행하고 져 Gy 이후에 축소조사시 비동일 평면 3차원 입체조형치료를 시행하는 방법이다. 위 3가지 치료계획은 모두 70.2 Gy의 선랸을 계획용 표적체적내 회전중심점에 처방하여 각 치료계획마다 계획용 표적체적과 이하선의 등선량 분포, 선량체적 히스토그람(dose volume histogram, DVH), 선량통계(dose statistics), 정상조직손상확률(normal tissue complication probability, NTCP)을 비교하였다. 결과 : 전 예의 환자에서 치료 표적 부위의 등선량 분포, 선량통계와 선량체적 히스토그람상 치료계획-C에서 치료선량이 표적체적 내에 보다 균일하게 조사되었다. 선량통계분석에서 이하선에 조사되는 평균 방사선량은 치료계획-C에서 가장 적었으며(치료계획-A 58 Gy, 치료계획-B 50 Gy, 치료계획-C 48.5 Gy), 46 Gy가 조사되는 체적도 가장 적었다(치료계획-A 100$\%$, 치료계획-B 98$\%$, 치료계획-C 69$\%$). 선량체적 히스토그람도 치료계획-C에서 가장 우수하였고, 선량체적 히스토그람을 이용하여 계산된 정상조직 부작용 확률도 치료계획-C에서 가장 낮았다. 결론 : 방사선치료 초기부터 3차원 입체조형치료를 적용하여 이하선을 치료 조사영역에서 제외하고, 축소 조사시에 다양한 조사방향을 가능하게 하기 위해 45 Gy 이전에 척수 차폐(spinal cord block)를 적용하는 이 같은 새로운 방사선치료 기법이 림프절 전이가 없는 비인강암의 환자에서 구강 건조증 발생을 감소시키는 방사선치료기법으로 추천될 수 있다고 사료된다.

  • PDF